Outpatient and Home Pelvic Floor Training for Stress Urinary Incontinence
Outpatient Pelvic Floor Muscle Training Versus Home Pelvic Floor Muscle Training for Stress Urinary Incontinence: Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
São Paulo, Brazil, 05311030
- Fátima Faní Fitz
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
SUI and mixed urinary incontinence with predominant symptoms of SUI with ≥ 2 g of leakage measured by pad test
Exclusion Criteria:
younger than 18 years old chronic degenerative diseases pelvic organ prolapse greater than stage I by POP-Q neurologic or psychiatric diseases inability to contract PFMs previously undergone pelvic floor re-education programs and/or previous pelvic floor surgeries
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Home pelvic floor muscle training
Patients will perform strength training of the pelvic floor muscles daily at home.
The training protocol consists of three sets of 30 slow contractions (type I muscle fibers), with maintenance contraction according to the initial evaluation, followed by three rapid contractions (type II muscle fibers) after each slow contraction.
The protocol will account for 90 contractions of the pelvic floor muscles per day.
At the end of one month, the patients will return for consultation, in which the MAP evaluation and training progression will be performed.
|
Patients will perform pelvic floor exercises at home.
|
|
Sham Comparator: Outpatient pelvic floor muscle training
The patients will perform 24 outpatient sessions of pelvic floor muscle strength training and home training.
The training protocol consists of three sets of 30 slow contractions (type I muscle fibers), with maintenance contraction according to the initial evaluation, followed by three rapid contractions (type II muscle fibers) after each slow contraction.
The protocol will account for 90 contractions of the pelvic floor muscles per day.
At the end of one month, the patients will perform the evaluation of the MAP and progression of the training.
|
Patients will perform pelvic floor exercises in the outpatient.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in pad test
Time Frame: Baseline, after 3 months of treatment
|
To quantify the severity of SUI and as the tool to estimate objective cure rate
|
Baseline, after 3 months of treatment
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in 7-Day Voiding Diary
Time Frame: Baseline and after 3 months of treatment
|
To assess the loss efforts
|
Baseline and after 3 months of treatment
|
|
Change in pelvic floor muscle function (Oxford Grading Scale)
Time Frame: Baseline and after 3 months of treatment
|
To assess the function of the pelvic floor muscle
|
Baseline and after 3 months of treatment
|
|
Change in Incontinence Quality-of-Life Questionnaire (I-QoL)
Time Frame: Baseline and after 3 months of treatment
|
To quantify the impact of SUI on quality of life
|
Baseline and after 3 months of treatment
|
|
Subjective cure of SUI ("satisfied" or "dissatisfied")
Time Frame: Baseline and after 3 months of treatment
|
To evaluate the patient satisfaction with treatment
|
Baseline and after 3 months of treatment
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Rodrigo A Castro, Universidade Federal de Sao Paulo
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 001 (Marta Eliza Miller Foundation)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.